Health News Releases

  • Today April 4
RNA THERAPIES GLOBAL CLINICAL TRIAL LANDSCAPE INFOGRAPHIC (Graphic: Business Wire)
September 18, 2024 09:45
Transforming the Future of Medicine with RNA-Based Therapies
Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, ha
September 13, 2024 15:35
MicroVention Rebrands to Terumo Neuro - Reflects Expanded Focus and Strategic Growth
MicroVention, Inc., a global leader in neurovascular innovation and a wholly owned subsidiary of Terumo Corporation, today announced its official rebranding to Terumo Neuro, effective immediately. Thi
September 13, 2024 14:30
ITM Obtains Exclusive Worldwide License from Debiopharm for CA IX-Targeted Peptide-based Radiopharmaceutical Programs Targeting Solid Tumors
ITM Isotope Technologies Munich SE (ITM) (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.globenewswire.com%2FTracker%3Fdata%3DknxVWFX97-AJVcLZDmqPUgpwJEhTXICkW7WWecPUpZ99eWRx-Db
Evan L. Tzanis, Chief Operating Officer and EVP of R&D, Neuraptive Therapeutics, Inc. (Photo: Busine
September 13, 2024 13:40
Neuraptive Therapeutics Receives FDA Breakthrough Therapy Designation for NTX-001 and Provides Update on the Advancements of NTX-001 for the Treatment of Peripheral Nerve Injury Requiring Repair
Neuraptive Therapeutics, Inc. today announced that NTX-001 has been granted Breakthrough Therapy Designation, thus providing the potential for accelerated development for patients with peripheral nerv
September 13, 2024 11:50
Novotech Unveils 2024 Report on Global Gastric Cancer Clinical Trials and Cutting-Edge Therapeutics
Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, ha
September 13, 2024 09:55
Novotech Wins Prestigious Brandon Hall Gold Award for CRA Monitoring Simulation Program under the category of Best Competencies and Skill Development
Novotech, a leading full-service clinical Contract Research Organization (CRO), is proud to announce that its Clinical Research Associate (CRA) Monitoring Simulation Program has been recognized with t
September 13, 2024 08:55
Merck Unveils New MAVENCLAD® Four-Year Data Highlighting Benefits of Early Treatment and Sustained Efficacy Across Multiple Measures of Disease Activity
Not intended for UK-, US- or Canada-based media Merck, a leading science and technology company, today announced presentations showcasing the long-term safety profile, sustained efficacy data, and
Dr. Yooni Kim, Managing Director APAC, Novotech (Photo: Business Wire)
September 12, 2024 13:50
Novotech Appoints Dr. Yooni Kim as a New Executive Position of Managing Director for APAC to Strengthen Global Expansion
Novotech, the leading global biotech Contract Research Organization (CRO), is pleased to announce the appointment of Dr. Yooni Kim as a new Executive position of Managing Director for the Asia-Pacific
(Graphic: Business Wire)
September 11, 2024 17:20
Novotech Honored with Frost & Sullivan’s 2024 Best Practices Company of the Year Award for Leadership in Biotech CRO Services
Novotech, the global full-service clinical Contract Research Organization (CRO), is proud to announce that it has been awarded the prestigious 2024 Global Company of the Year Award by Frost & Sullivan
September 11, 2024 11:05
CorFlow Therapeutics AG Completes €44 Million Series B Financing to Support the Advancement of a Novel Diagnostic and Drug Delivery Platform for Microvascular Obstruction (MVO) in Heart Attack Patients
CorFlow Therapeutics AG (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.corflow.com&esheet=54114953&newsitemid=20240910783655&lan=en-US&anchor=CorFlow+Therapeutics+AG&index=1&md5
Masimo SafetyNet® and Saint-Denis Hospital Center, Delafontaine (France) (Photo: Business Wire)
September 11, 2024 09:40
Saint-Denis Hospital Center in France Implements Masimo SafetyNet® Telemonitoring to Facilitate Early Discharge of Premature Newborns from the Hospital
Masimo (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.masimo.com&esheet=54118830&newsitemid=20240908136612&lan=en-US&anchor=Masimo&index=1&md5=34c96fb7c39ca290fc395f6f1f3b2eb9)
September 10, 2024 16:11
MRM Health Appoints Grégoire Franoux as Chief Business Officer and Adds Ron Robison to its Board of Directors
MRM Health NV, a clinical-stage biopharmaceutical company developing innovative therapeutics for inflammatory, CNS and metabolic diseases, today announced the appointment of Grégoire Franoux, M.B.A.,
September 06, 2024 10:40
Novotech Releases 2024 Report on Pancreatic Cancer Clinical Trials and Drug Development
Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, ha
Left: Controller (MLC-AC0-P*) / Right: Detector (MLC-AD240A-P*) / Bottom: Sensor module (MLC-AS240A-
September 05, 2024 14:15
PHC Launches LiCellMo™ Live Cell Metabolic Analyzer for Real-Time Visualization of Cellular Metabolism in Cell and Gene Therapies
PHC Corporation Biomedical Division (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.phchd.com%2Fglobal%2Fphc&esheet=54116517&newsitemid=20240903521355&lan=en-US&anchor=PHC+Corpo
Jason Monteleone, newly appointed president and CEO of Avania. (Photo: Business Wire)
September 05, 2024 11:15
Avania Appoints Recognized CRO and MedTech Industry Leader, Jason Monteleone, as New President and CEO
Avania (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.avaniaclinical.com%2F&esheet=54116875&newsitemid=20240904978746&lan=en-US&anchor=Avania&index=1&md5=42bb77e18075e818ffddfc
Histotripsy patient Marie and her husband Steve after Marie’s histotripsy treatment of her liver tum
September 04, 2024 16:10
HistoSonics® Publishes Results of its Pivotal #HOPE4LIVER Trials
HistoSonics, (www.histosonics.com), the developer and manufacturer of the Edison® Histotripsy System, announced today the publication of the company’s pivotal clinical trials data in Radiology (https:
EDT device (Photo: Business Wire)
September 04, 2024 14:35
Rigaku: Novel Electron Density Topography Technology to Reveal Biological Macromolecules’ Properties
Rigaku Corporation, a Rigaku Holdings Group company and global partner for X-ray analysis from Lab to Fab (headquarters: Akishima, Tokyo; president and CEO: Jun Kawakami; “Rigaku”), has developed a te
August 30, 2024 08:39
Merck Announces First Patient Dosed in Phase III Study of Oral Cladribine in Generalized Myasthenia Gravis (gMG)
Not intended for UK-, US- or Canada-based media Merck, a leading science and technology company, today announced the first patient has been dosed in the Phase III MyClad trial (NCT06463587 (https:/
August 29, 2024 15:50
Galderma Successfully Issued an Inaugural CHF 500 Million Bond
Galderma Group AG (SWX:GALD): NOT FOR DISTRIBUTION IN THE UNITED STATES OR IN ANY OTHER JURISDICTION IN WHICH SUCH DISTRIBUTION WOULD BE RESTRICTED BY APPLICABLE LAW OR REGULATION Galderma succe
August 29, 2024 14:15
Novotech Earns Renewed Certification as an Employer of Choice for Gender Equality
Novotech, a global full-service clinical Contract Research Organization (CRO), proudly announces its continued recognition as a Workplace Gender Equality Agency (WGEA) Employer of Choice for Gender Eq
Mr. Li Ka-shing Gifts Histotripsy Systems to Hong Kong Hospitals with Liver Team, 27 Aug. 2024. (Pho
August 29, 2024 14:00
HistoSonics™ Partners with Li Ka Shing Foundation to Launch First Histotripsy Programs in Hong Kong
HistoSonics, (www.histosonics.com), the developer and manufacturer of the Edison™ Histotripsy System, announced today the company’s initial partnership in Asia with Hong Kong University receiving thei
Left: Andrew Wong, Chief Executive Officer/General Manager of Shanghai Wotai Biotechnology, China Ri
August 28, 2024 16:50
Avantor Triumphs with Three Awards at Korea Biopharma Excellence Awards 2024
Avantor, Inc., a leading global provider of mission-critical products and services to customers in the life sciences advanced technologies industries, has secured three prestigious awards at the estee
PCI becomes first drug product CDMO to navigate ICMRA multi-agency inspection process. (Photo: Busin
August 22, 2024 14:05
PCI Pharma Services’ Bedford, New Hampshire Location Successfully Completes International Coalition of Medicines Regulatory Authorities Inspection
PCI Pharma Services (PCI), a leading global contract development and manufacturing organization (CDMO), has successfully completed the International Coalition of Medicines Regulatory Authorities (ICMR
August 21, 2024 14:45
Organon & Lilly Expand Migraine Commercialization Agreement to 11 Additional Markets
Organon (NYSE: OGN), a global healthcare company with a focus on women’s health, announced it has expanded its agreement with Eli Lilly and Company (Lilly) to become the sole distributor and promoter
August 20, 2024 15:55
Guard Medical Announces FDA 510(k) Clearance for Additional Large Sizes of Its Novel NPseal® NPWT Surgical Dressing, Unlocking the Orthopedic Market
Privately-held company Guard Medical Inc. (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.guard-medical.com%2F&esheet=54110779&newsitemid=20240819281623&lan=en-US&anchor=Guard+Me
25 per page50 per page75 per page100 per page